Healthcare doesn’t fail because leaders don’t care.
Healthcare doesn’t fail because leaders don’t care.
It fails when complexity outpaces visibility, alignment, and execution.
Whether driven by care providers or business leaders, we work with organizations facing the same reality: risk, margin compression, operational fragmentation, and revenue leakage hidden deep inside their workflows.
It fails when complexity outpaces visibility, alignment, and execution.
Whether driven by care providers or business leaders, we work with organizations facing the same reality: risk, margin compression, operational fragmentation, and revenue leakage hidden deep inside their workflows.
PHYSICIAN PRACTICES & MEDICAL GROUPS
PHYSICIAN PRACTICES & MEDICAL GROUPS
Physician practices are operating in a high-friction environment: rising costs, payer pressure, staffing volatility, and mounting administrative burden. Many are reacting to symptoms without clarity on root causes.
We work with independent and multi-site groups across specialties to restore operational and financial control.
Common challenges we see:
✔ Revenue cycle issues masked by headline performance
✔ Denials, underpayments, and authorization failures normalized as “part of the business”
✔ Service lines that appear profitable but actually drain cash and resources
✔ Operational workflows that rely on manual intervention and individual heroics
Our team provides rapid diagnostic clarity.
✔ Audits revenue cycle systems and workflows end to end
✔ Identifies and quantifies denial risk and reimbursement leakage
✔ Distinguishes payer behavior from internal execution gaps
✔ Creates a clear, defensible baseline for improvement
The objective isn't perfection, it's greater control, confidence, and the ability to serve patients better.
Physician practices and medical groups are operating in one of the most unforgiving environments in decades.
Rising operating costs, payer friction, staffing instability, and increasing administrative burden are forcing many practices into reactive mode—often without a clear understanding of where performance is breaking down.
We work with independent practices and multi-site medical groups across specialties to help them regain control.
Common challenges we see include:
✔ Revenue cycle issues masked by headline performance
✔ Denials, underpayments, and authorization failures normalized as “part of the business”
✔ Service lines that look profitable on paper but strain cash flow
✔ Operational workflows that rely on manual intervention and individual heroics
RevPulse provides rapid diagnostic clarity.
For physician practices and medical groups, RevPulse:
✔ Audits revenue cycle systems and workflows end to end
✔ Identifies denial risk, control failures, and reimbursement leakage
✔ Distinguishes payer behavior from internal execution issues
✔ Creates a clear, defensible baseline for improvement
Our team then works alongside practice leadership and operations—not above them—to:
✔ Stabilize revenue cycle performance
✔ Strengthen front-end controls and workflows
✔ Support smart expansion into infusion or specialty services when appropriate
We bring operator-level experience across clinical operations, revenue cycle, payer contracting, and growth strategy. The objective is not perfection—it is control, confidence in the numbers, and the ability to serve patients better while working smarter.
FEDERALLY QUALIFIED HEALTH CENTERS
FQHCs operate under structural constraints: PPS reimbursement, Medicaid concentration, 340B compliance, grant oversight, and mission-driven access mandates.
As margin tightens and patient acuity rises, many FQHCs are evaluating infusion and specialty services to stabilize the enterprise. Expansion without rigorous modeling, however, can create material financial and regulatory risk.
We help FQHC leadership determine what strengthens the system — and what introduces exposure.
✔ PPS vs. FFS reimbursement dynamics across Medicaid, Medicare, and MCO contracts
✔ Drug reimbursement strategy, authorization failure points, and denial drivers ✔ Staffing matrices and policies, protocols, and regulatory compliance frameworks
For FQHCs, RevPulse delivers an enterprise-wide diagnostic across revenue integrity, workflow execution, and reimbursement performance, enabling leadership to see:
✔ Where revenue is leaking across the organization
✔ Which service lines are structurally sound versus deceptively fragile
✔ Whether new services will improve margin or simply shift risk
Federally Qualified Health Centers (FQHCs) are a cornerstone of community-based care, providing essential access to primary and specialty services for medically underserved populations. Their ability to remain financially stable and operationally resilient is critical to the communities that depend on them.
Mission demands continue to rise while financial flexibility tightens. In response, many FQHCs are evaluating ancillary revenue and advanced specialty services — such as infusion and specialty service lines — to sustain access, staffing, and long-term viability.
But expansion without clarity creates risk.
We help FQHCs determine:
✔ Whether infusion or specialty care is strategically viable given payer mix, patient demand, staffing, and regulatory constraints
✔ Where revenue and operational leakage already exists, often across multiple service lines
✔ Which opportunities strengthen the enterprise versus quietly adding complexity and financial exposure
FQHCs operate under structural constraints: PPS reimbursement, Medicaid concentration, 340B compliance, grant oversight, and mission-driven access mandates.
As margin tightens and patient acuity rises, many FQHCs are evaluating infusion and specialty services to stabilize the enterprise. Expansion without rigorous modeling, however, can create material financial and regulatory risk.
We help FQHC leadership determine what strengthens the system — and what introduces exposure.
✔ PPS vs. FFS reimbursement dynamics across Medicaid, Medicare, and MCO contracts
✔ Drug reimbursement strategy, authorization failure points, and denial drivers ✔ Staffing matrices and policies, protocols, and regulatory compliance frameworks
For FQHCs, RevPulse delivers an enterprise-wide diagnostic across revenue integrity, workflow execution, and reimbursement performance, enabling leadership to see:
✔ Where revenue is leaking across the organization
✔ Which service lines are structurally sound versus deceptively fragile
✔ Whether new services will improve margin or simply shift risk
For FQHCs, RevPulse delivers an enterprise-wide diagnostic across revenue integrity, workflow execution, and reimbursement performance, enabling leadership to see:
✔ Where revenue is leaking across the organization
✔ Which service lines are structurally sound versus deceptively fragile
✔ Whether new services will improve margin or simply shift risk
HEALTH SYSTEMS & HOSPITALS
HEALTH SYSTEMS & HOSPITALS
HEALTH SYSTEMS & HOSPITALS
Health systems and hospitals must simultaneously improve underperforming HOPDs and build ambulatory infusion capacity to address payer steerage, network leakage, and competition from lower-cost sites of care. Without structural alignment, outpatient infusion becomes a margin drag rather than a strategic asset.
Our team has built and scaled some of the largest infusion platforms in the country. We leverage that experience to design and execute ambulatory infusion strategies that:
✔ Underperform financially while appearing stable in consolidated reporting ✔ Reduce network leakage and defend referral capture
✔ Standardize clinical workflows across sites
✔ Optimize staffing, inventory, and facility design for outpatient economics
We design and execute ambulatory infusion strategies that reduce network leakage, align payer contracts and ASP-based reimbursement, standardize workflows across sites, and optimize staffing, inventory, and facility design for outpatient economics.
Health systems and hospitals must simultaneously improve underperforming HOPDs and build ambulatory infusion capacity to address payer steerage, network leakage, and competition from lower-cost sites of care. Without structural alignment, outpatient infusion becomes a margin drag rather than a strategic asset.
Our team has built and scaled some of the largest infusion platforms in the country. We leverage that experience to design and execute ambulatory infusion strategies that:
✔ Underperform financially while appearing stable in consolidated reporting ✔ Reduce network leakage and defend referral capture
✔ Standardize clinical workflows across sites
✔ Optimize staffing, inventory, and facility design for outpatient economics
We design and execute ambulatory infusion strategies that reduce network leakage, align payer contracts and ASP-based reimbursement, standardize workflows across sites, and optimize staffing, inventory, and facility design for outpatient economics.
HOPDs are often the quiet profit killers inside health systems.
Health systems today face pressure from payor steerage, declining patient satisfaction and compliance, competition from independent sites of care, and network leakage. Nowhere are these forces more concentrated than in hospital outpatient departments—particularly infusion.
In many systems, HOPDs:
✔ Underperform financially while appearing stable in consolidated reporting
✔ Suffer from chronic revenue cycle dysfunction normalized as complexity
✔ Operate with cost structures misaligned to outpatient reimbursement
✔ Quietly erode margin—and in some cases materially weaken the system
Our team has built and scaled some of the largest infusion platforms in the country.
RevPulse is purpose-built for HOPDs. It allows us to:
✔ Isolate underperforming outpatient sites with precision
✔ Distinguish reimbursement issues from operational failures
✔ Quantify margin erosion by site, service line, and payer
✔ Identify where scale amplifies losses rather than efficiencies
We help systems design ambulatory infusion strategies built on their existing enterprise foundation—not bolt-on solutions that increase fragmentation.
AMBULATORY INFUSION CENTERS
AMBULATORY INFUSION CENTERS
Infusion is a complex business. Scaling must be intentional.
Whether launching a first site or expanding beyond an initial footprint, AICs face margin compression, payer behavior, and workflow breakdowns that often surface only after growth is underway.
RevPulse quickly exposes:
✔ Hidden drivers of margin erosion
✔ Risk concentration across therapies, payers, or sites
✔ Whether the operating model will hold under scale or fracture
Our data-driven market analysis, insights, and support with disciplined execution allows your team to better detect and address gaps, proactively and systematically.
Infusion is a complex business. Scaling must be intentional.
Whether launching a first site or expanding beyond an initial footprint, AICs face margin compression, payer behavior, and workflow breakdowns that often surface only after growth is underway.
RevPulse quickly exposes:
✔ Hidden drivers of margin erosion
✔ Risk concentration across therapies, payers, or sites
✔ Whether the operating model will hold under scale—or fracture
Our work with platforms such as Flourish Health reinforces a core truth: Successful infusion growth requires data-driven market analysis and disciplined execution—not hope or anecdote.
PRIVATE EQUITY & INVESTORS
PRIVATE EQUITY & INVESTORS
Private equity and strategic investors continue to show strong appetite for infusion platforms, driven by specialty drug growth, site-of-care migration, and recurring revenue characteristics. The opportunity is real, but operational fragility, reimbursement complexity, and execution gaps can erode value quickly.
We support investors by:
✔ Conducting operator-led diligence across revenue cycle, clinical workflows, drug procurement economics, and payer contract performance ✔ Deploying RevPulse to uncover site-level margin erosion, denial normalization, and cash-flow distortions traditional financial reviews miss ✔ Stress-testing reimbursement durability, ASP exposure, payer concentration, and scalability assumptions ✔ Leading post-close stabilization, control remediation, and disciplined value creation tied to measurable EBITDA lift
Private equity and strategic investors continue to show strong appetite for infusion platforms, driven by specialty drug growth, site-of-care migration, and recurring revenue characteristics. The opportunity is real, but operational fragility, reimbursement complexity, and execution gaps can erode value quickly.
We support investors by:
✔ Conducting operator-led diligence across revenue cycle, clinical workflows, drug procurement economics, and payer contract performance ✔ Deploying RevPulse to uncover site-level margin erosion, denial normalization, and cash-flow distortions traditional financial reviews miss ✔ Stress-testing reimbursement durability, ASP exposure, payer concentration, and scalability assumptions ✔ Leading post-close stabilization, control remediation, and disciplined value creation tied to measurable EBITDA lift
See How We Support Organizations Like Yours
See How We Support Organizations Like Yours
Connect with our team and let's talk
Connect with our team and let's talk
